Description: The active ingredient is Interferon beta-1a (6 million IU) and the other ingredients are: Human serum albumin, sodium chloride, dibasic sodium phosphate and monobasic sodium phosphate. Interferon beta-1a helps to regulate your body’s immune system.
The pharmacokinetics of interferon beta-1a in people with multiple sclerosis have not been evaluated. In healthy subjects, a single subcutaneous (SC) injection of 60 mcg of interferon beta-1a (liquid formulation).
INN: Interferon Beta-1a
Indication: Relapsing forms of multiple sclerosis
Protein type: Interferon
Mechanism of action: Interferon beta upregulates the expression of MHC I proteins, allowing for increased presentation of peptides derived from viral antigens. This enhances the activation of CD8+ T cells that are the precursors for cytotoxic T lymphocytes (CTLs) and makes the macrophage a better target for CTL-mediated killing. Whether the mechanism of action of Cinnovex in MS is mediated by the same pathway as the biological effects described above is not known because the pathophysiology of MS is not well established.